Nim-Response
Payments companies reported to CMS as associated with Nim-Response. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nim-Response, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nim-Response
These are the largest totals companies reported as associated with Nim-Response. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jack Kartush | Farmington Hills, MI | Otolaryngology | $20,800.00 |
| Kevin Peng | Los Angeles, CA | Otology & Neurotology | $10,798.96 |
| John Mcelveen | Raleigh, NC | Otology & Neurotology | $7,857.32 |
| Elizabeth Toh | Burlington, MA | Otolaryngology | $7,557.09 |
| Seilesh Babu | Farmington Hills, MI | Otology & Neurotology | $7,024.14 |
| Simon Angeli | Miami, FL | Otology & Neurotology | $6,197.21 |
| Simon Holoubek | Rockford, IL | Surgery | $6,066.11 |
| Gregory Randolph | Boston, MA | Otolaryngology | $5,760.00 |
| Ralph Tufano | Sarasota, FL | Otolaryngology | $4,455.30 |
| Esther Vivas | Atlanta, GA | Otology & Neurotology | $4,250.00 |
Prescribed Nim-Response?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.